Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Masimo Corporation - Common Stock (NQ:MASI)

155.13 -0.49 (-0.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
2 Under-the-Radar Medtech Stocks to Buy Now
Don't count out these discounted medical technology stocks. 
Via The Motley Fool
Masimo to Report Third Quarter 2022 Financial Results after Market Close on Tuesday, November 8
From Masimo
Via Business Wire
NASDAQ:MASI Investor Notice: Investigation over Possible Securities Laws Violations by Masimo Corporation
San Diego, CA -- (SBWIRE) -- 10/25/2022 -- An investigation was announced concerning possible violations of securities laws by Masimo Corporation in connection with certain financial statements. 
Via SBWire
Masimo Sets the Record Straight on Bylaw Amendments
From Masimo
Via Business Wire
Politan Capital Management Takes Legal Action in Response to Masimo’s Attempts to Eliminate Stockholder Rights
From Politan Capital Management
Via Business Wire
Where Masimo Stands With Analysts
Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Where Masimo Stands With Analysts
Within the last quarter, Masimo (NASDAQ:MASI) has observed the following analyst ratings: 
Via Benzinga
Masimo Clocks 85% Jump In Quarterly Sales, Provides Q3 Guidance Below Expectations
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
7 Analysts Have This to Say About Masimo
Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues
Via Benzinga
Accenture Price Target Cut By This Analyst, Plus Deutsche Bank Predicts $483 For FactSet Research
Credit Suisse cut FedEx Corporation (NYSE: FDX) price target from $246 to $236. FedEx shares fell 1.9% to $151.56 in pre-market trading. 
Via Benzinga
Masimo Appoints New Leader for Consumer Division
From Masimo
Via Business Wire
Medical Pioneer Masimo Announces the Full Market Consumer Release of the Masimo W1™, the First Watch to Offer Accurate, Continuous Health Data
From Masimo
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022
Upgrades 
Via Benzinga
Citigroup Slashes Price Target On This Stock By 83%; Also Check Out Some Other Big PT Changes
RBC Capital cut the price target for Nuvei Corporation (NASDAQ: NVEI) from $80 to $60. Nuvei shares fell 21.5% to close at $33.03 on Tuesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low... 
Via Benzinga
Masimo Reports Second Quarter 2022 Financial Results
From Masimo
Via Business Wire
Masimo to Report Second Quarter 2022 Financial Results after Market Close on Tuesday, August 9
From Masimo
Via Business Wire
Randomized Controlled Study Finds Masimo SedLine® Brain Function Monitoring Can Help Guide Anesthesia in Children Undergoing Minor Surgery
From Masimo
Via Business Wire
7 Best High-Growth Stocks for Young Investors
The best high-growth stocks for young investors are poised to outperform once again once the markets turn positive. 
Via InvestorPlace
Two-part Study Finds That Remote Patient Monitoring with Masimo SafetyNet® Reduced Length of Hospital Stay for COVID-19 Patients
From Masimo
Via Business Wire
New Study Finds That Masimo PVi® May Be Useful in Helping ER Doctors Determine the Severity of Asthma Attacks in Pediatric Patients
From Masimo
Via Business Wire
Masimo's Return on Invested Capital Insights
According to Benzinga Pro, during Q1, Masimo (NASDAQ:MASI) earned $46.59 million, a 31.74% increase from the preceding quarter. Masimo's sales decreased to $304.24 million, a 7.12% change since Q4. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Masimo Reports First Quarter 2022 Financial Results
From Masimo
Via Business Wire
Masimo's Earnings Outlook
Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an... 
Via Benzinga
Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1™ Watch for Consumers
From Masimo
Via Business Wire
Masimo SedLine® Brain Function Monitoring Reduced the Use of Anesthetic Agents and Opioids in a Study on Patients Undergoing Cardiac Surgery
From Masimo
Via Business Wire
New JAMA Article Highlights the Outcome and Safety Benefits of Remote Patient Monitoring During the Pandemic and Beyond
From Masimo
Via Business Wire
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.